Andy Crump is a consultant at the Medical Governance Research Institute and a visiting professor at Kitasato University, Keio University and St Luke's International University in Tokyo.
The days when we could unquestioningly trust science and scientists are long gone. If anything, the rush to approve medicines without proper testing for the COVID-19 pandemic should give us even less faith in how our drug approval procedures and public health systems are run. Take the case of the antiviral drug remdesivir.
